Advanced Medicine 2018: Meet the speakers

Our upcoming Advanced Medicine conference – taking place on 5-8 February 2018 – will combine sessions on the latest research, with expert discussion of topical clinical controversies. Here we profile a selection of speakers and highlight the topics they will be exloring.

Dr Richard Scott

Monday 5 February, 11am - 100,00 genomes: Rare diseases

Dr Scott is clinical lead for rare disease for the 100,000 Genomes Project at Genomics England. He is also a consultant and honorary senior lecturer in clinical genetics at Great Ormond Street Hospital for Children and the UCL Institute of Child Health.

An insight into Dr Scott’s session

Dr Scott's talk will describe the systems that Genomics England has built to deliver the programme and the next steps to develop a diagnostic pipeline for the NHS.

Professor Adrian Martineau

Tuesday 6 February, 4pm - The case for vitamin D fortification in the UK

Professor Martineau is clinical professor of respiratory infection and immunity at Barts and the London School of Medicine and Dentistry, Queen Mary University of London. He is a respiratory physician with a research interest in the effects of vitamin D on human health.

An insight into Professor Martineau’s session

In this talk, Professor Martineau will explore alternative strategies to achieve the new RNI for vitamin D, including fortifying commonly consumed foods with vitamin D.

Professor Roy Taylor

Tuesday 6 February, 4.30pm - Calorie restriction for long term remission of type 2 diabetes

Professor Taylor qualified in medicine at the University of Edinburgh. He is professor of medicine and metabolism at Newcastle University and an honorary consultant at Newcastle Hospitals NHS Foundation Trust. He has been conducting research on type 2 diabetes since 1978, and he has used a wide range of methods to understand the condition.

An insight into Professor Taylor’s session

Professor Taylor will present the results of the recent trial in reversing type 2 diabetes in primary care (the Diabetes Remission Clinical Trial (DiRECT)).

Professor Volker Straub

Wednesday 7 February, 4.35pm - Muscular Dystrophy

Professor Straub trained as a paediatric neurologist at the University of Düsseldorf and the University of Essen in Germany. After completing his PhD thesis on Duchenne muscular dystrophy, he worked as a postdoctoral research fellow at the University of Iowa. In 2003 Professor Straub joined Newcastle University as the Harold Macmillan professor of medicine.

He is the deputy director of the Institute of Genetic Medicine and director of the Newcastle University John Walton Muscular Dystrophy Research Centre.

An insight into Professor Straub’s session

In this session, Professor Straub will discuss the advent of molecular genetic therapies, and how personalised medicine has opened up new avenues and raised hopes that one day a cure for this debilitating orphan disease will be found.

Professor Philip Hawkins

Thursday 8 February, 10am - Amyloid

Professor Hawkins studied medicine at St George’s Hospital Medical School and qualified in 1982. Following his training in rheumatology at the Hammersmith Hospital, he obtained his PhD with Professor Mark Pepys working on in vitro and experimental models of amyloidosis, and he began to translate this work into the few patients who were diagnosed during the 1980s and 1990s.

Professor Hawkins has worked in amyloidosis and related disorders ever since, and he was commissioned by the NHS to provide a national diagnostic and management advisory service for these disorders in 1999 at the Royal Free Hospital.

An insight into Professor Hawkins’ session

This session will provide an overview of current diagnosis and management of amyloidosis and inherited autoinflammatory diseases, with an emphasis on developments in imaging and new treatments. These notably include multiparametric cardiac MRI, the non-biopsy diagnosis of transthyretin (ATTR) amyloidosis, RNA inhibitors, monoclonal antibodies and cytokine blockade.